Le Lézard
Classified in: Health, Science and technology

Global RNA Therapy Market Analysis & Outlook: 2017-2019 & 2025 - Rising Genetic Diseases, Neurological Disorders and Viral Infections - ResearchAndMarkets.com


The "RNA Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global RNA therapy market to grow with a CAGR of 8.5% over the forecast period from 2019-2025.

The report on the global RNA therapy market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on RNA therapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on RNA therapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global RNA therapy market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global RNA therapy market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

2) Restraints

3) Opportunities

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the RNA therapy market.

2. Complete coverage of all the segments in the RNA therapy market to analyze the trends, developments in the global market and forecast of market size up to 2025.

3. Comprehensive analysis of the companies operating in the global RNA therapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. RNA Therapy Market Highlights

2.2. RNA Therapy Market Projection

2.3. RNA Therapy Market Regional Highlights

3. Global RNA Therapy Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Technology

3.4.2. Growth Matrix Analysis by Application

3.4.3. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of RNA Therapy Market

4. RNA Therapy Market Macro Indicator Analysis

5. Global RNA Therapy Market by Technology

5.1. Enabling Technologies

5.2. Enabled Technologies

5.3. RNA Antisense Technologies

5.4. RNA Interference (RNAi) Technologies

6. Global RNA Therapy Market by Application

6.1. Kidney Diseases

6.2. Cardiovascular

6.3. Infectious Diseases

6.4. Oncology

6.5. Metabolic Disorders

6.6. Other Applications

7. Global RNA Therapy Market by Region

7.1. North America

7.2. Europe

7.3. Asia-Pacific

7.4. RoW

8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global RNA Therapy Market

8.2. Companies Profiled

8.2.1. Silence Therapeutics

8.2.2. Cenix BioScience GmbH

8.2.3. Sanofi Genzyme

8.2.4. Benitec Biopharma Ltd.

8.2.5. Arbutus Biopharma Corporation

8.2.6. DiceRNA Pharmaceuticals

8.2.7. Alnylam Pharmaceuticals Inc.

8.2.8. Quark Pharmaceuticals

8.2.9. Other Companies

For more information about this report visit https://www.researchandmarkets.com/r/6ocse0


These press releases may also interest you

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
Media Advisory - Minister Saks in Winnipeg to highlight Budget 2024: Fairness for Every Generation investments to boost research funding in Canada
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Tim Kennedy, and Dan Hollaway
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation Expands Reach to Virginia and Louisiana
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated Revises Time of First Quarter Webcast Teleconference to 7:00 a.m. (ET) on Thursday, May 2, 2024
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...

at 17:48
Hundreds of Community Leaders Kick Off Multi-city Convening in Bakersfield With a Simple Message: Do Not Cut San Joaquin Valley Programs & Services
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

More news about Health...


News published on and distributed by: